MPI Research Inc Our company has conducted thousands of drug safety, discovery, bioanalytical, and analytical studies. We offer extensive support and resources including, but not limited to: A wide and diverse range of classes of compounds; All routes of administration except inhalation; Studies with numerous species and models; Comprehensive reporting capabilities. Flexibility and ample capacity enable us to: Accommodate multiple requirements simultaneously; Adjust schedules readily; Produce results quickly. Working in partnership with pharmaceutical, biotech, medical device, and chemical companies, we conduct customized preclinical research throughout the discovery and development process, from early proof of concept testing to regulatory submissions, including IND, EPA/OPPTS, NDA, PMA, and 510K.